Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BP | XOM |
|---|---|---|
| Price | $44.41 | $162.14 |
| Change today | ▼ 0.18% | ▲ 0.56% |
| Market cap | $114.37B | $666.71B |
| Return, 3 months | +19.2% | +18.6% |
| Return, year to date | +32.6% | +37.4% |
| Return, 1 year | +32.4% | +44.3% |
| P/E (TTM) | 21.2 | 20.9 |
| P/B | 2.0 | 2.6 |
| P/E percentile vs own 5y | 70th | 90th |
| Dividend yield | 4.50% | 2.52% |
| Revenue growth (YoY, latest qtr) | +48.2% | +44.1% |
| Net profit growth (YoY) | +124.5% | +102.4% |
| Gross margin | 20.0% | 20.6% |
| Operating margin | 11.4% | 10.7% |
| Net margin | 2.5% | 9.1% |
| Return on equity | 9.2% | 12.6% |
| Analyst target vs. price | +2.9% | +4.9% |
| Analyst buy share | 14% | 50% |
| RSI (14) | 52 | 52 |
| 30-day volatility | 28.1% | 25.7% |
| Max drawdown, 1 year | -23.2% | -20.1% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.